USX:XGN - Exagen Inc Exagen Inc
Sector: Health Care, Industry: Life Sciences Tools & Services
Add to Watchlist
   
Add Alert 


Yahoo Finance


Exagen to Announce First Quarter Financial Results on May 11, 2020

27 Apr 2020 - Yahoo News
SAN DIEGO, April 27, 2020 -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic.
usx:xgn

Exagen Inc. Reports Fourth Quarter and Full Year 2019 Results

25 Mar 2020 - Yahoo News
SAN DIEGO, March 25, 2020 -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic.
usx:xgn

Exagen Inc to Host Earnings Call

25 Mar 2020 - Yahoo News
NEW YORK, NY / ACCESSWIRE / March 25, 2020 / Exagen Inc (NASDAQ:XGN) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 25, 2020 at 4:30 PM Eastern ...
usx:xgn

Exagen Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer, and Anja Kammesheidt, Ph.D., as Chief Scientific Officer

24 Mar 2020 - Yahoo News
Exagen Inc. (XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced the appointment of Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer (CMO), and Anja Kammesheidt, Ph.D., as Chief Scientific Officer (CSO). The addition ...
usx:xgn

Exagen Inc. Partners with Sonora Quest Laboratories to Offer AVISE Testing for Patients Suspected of Autoimmune Disease

16 Mar 2020 - Yahoo News
Exagen Inc. (XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention, today announced that it has entered into a strategic partnership ...
usx:xgn

Exagen to Announce Fourth Quarter and Year-End 2019 Financial Results on March 25, 2020

11 Mar 2020 - Yahoo News
SAN DIEGO, March 11, 2020 -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic.
usx:xgn

Exagen Inc. Partners with Three California Medical Groups to Offer AVISE Testing as Covered In-Network Benefit for Their Patients

9 Mar 2020 - Yahoo News
Exagen Inc. (XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention, today announced three large medical groups across California have ...
usx:xgn

Exagen to Present at Cowen and Company 40th Annual Healthcare Conference

18 Feb 2020 - Yahoo News
SAN DIEGO, Feb. 18, 2020 -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic.
usx:xgn

Is Exagen (NASDAQ:XGN) A Risky Investment?

22 Jan 2020 - Yahoo News
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
usx:xgn

Do Hedge Funds Love Exagen Inc. (XGN)?

20 Dec 2019 - Yahoo News
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 of 2018 due to various reasons. Nevertheless, the data show elite investors' consensus picks have done well on average over the long-term. The top 20 stocks ...
usx:xgn

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T4

About · FAQs · StocksCafe © 2024 · Privacy · Terms